A multidisciplinary approach for better Pancreatic Cancer care
Pancreatic cancer is the fifth leading cause of cancer death in Europe. As cases are almost always diagnosed at an advanced stage, and with few treatment options available, the resulting 5-year survival rates are among the lowest (<5%) of any cancer.
The Essential Requirements for Quality Cancer Care: Pancreatic Cancer has been released in conjunction with the final conference of Innovative Partnership for Action Against Cancer (IPAAC) in Ljubljana, Slovenia (13-14 December 2021), calling for quality frameworks in expert MDTs (multidisciplinary teams).
Developed under the initiative of the European Cancer Organisation and sponsored by the Innovative Partnership for Action Against Cancer, this new consensus charter for improved care and standards for a too-long neglected tumour type sets out in clear terms how health systems in all countries can better organise the key elements of service and treatment to pancreatic cancer patients. Such change is urgently needed to improve outcomes for pancreatic cancer care.
It was created in the context of driving up quality in cancer care across Europe. Written by European experts representing all disciplines involved in cancer care, including ESSO representative Professor Stefano Partelli, it points out complex diagnosis in Pancreatic Cancer and the remaining challenges. It gives focus on the importance of the high-quality multidisciplinary treatment for Pancreatic Cancer patients.
Prof. Stefano Partelli, Associate Professor at Libera Università Vita-Salute San Raffaele in Italy and Co-Chair of the E.C.O. Working Group on Essential Requirements for Quality Cancer Care: Pancreatic Cancer, stressed: “Pancreatic cancer is still a neglected cancer despite its increasing incidence. A multidisciplinary approach is critical for optimizing the management of patients, and for improving outcomes especially when surgery is needed. The Essential Requirements for Quality Cancer Care: Pancreatic Cancer are important tools for moving into this direction.”
The paper is available here.
The Innovative Partnership for Action Against Cancer (iPAAC) Joint Action brings together 24 Associated Partners (with Affiliated Entities, 44 partners) across Europe whose main objectives are to build upon deliverables of the CANCON Joint Action and to implement innovative approaches to cancer control. A Roadmap on Implementation and Sustainability of Cancer Control Actions will be the main deliverable of this Joint Action.